Azilsartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C25H20N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F9NUX55P23, chemically known as 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid but generally known as Azilsartan, which bears US NIH Compound Identifier 9825285. European Medicines Agency schedules Azilsartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31561. The term AZILSARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, No. 1, 2007, List 57). Most nations schedule azilsartan under HS 29349990 and SITC 51579. As of Q4 2014, AZILSARTAN remains the US FDA Preferred Term for this commodity. Azilsartan bears US NLM identifiers UMLS ID C1958569 and NCI Concept Code C75107. SMILES: CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)O.